VII. Are lymphomas driven by epigenetic lesions?

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1069|33|S1|42-45

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.33, Iss.S1, 2015-06, pp. : 42-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenetic Lesions in Malignant Melanoma

By  

Current Pharmaceutical Biotechnology, Vol. 8, Iss. 6, 2007-12 ,pp. : 382-387

Bentham Science Publishers

Access to resources Recommend Favorite

Driven Hematopoietic Differentiation of Embryonic Stem Cells: Epigenetic Perspectives

By  

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1674-1686

Bentham Science Publishers

Access to resources Recommend Favorite

Driven to it

By Roberts Trudie  

Clinical Medicine, Vol. 12, Iss. 3, 2012-06 ,pp. : 207-209

Royal College Of Physicians

Access to resources Recommend Favorite

Radioimmunotherapy of Non-Hodgkin's Lymphomas

By  

Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. : 1293-1300

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Hodgkin's Lymphomas

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 4, 2008-04 ,pp. : 356-356

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite